Federica Marchesi
Overview
Explore the profile of Federica Marchesi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
5311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S, et al.
Commun Biol
. 2025 Feb;
8(1):295.
PMID: 39988700
No abstract available.
2.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S, et al.
Commun Biol
. 2025 Jan;
8(1):99.
PMID: 39838096
Tregs for adoptive therapy are traditionally expanded ex vivo using high doses of IL-2. However, the final Treg product has limited survival once infused in patients, potentially affecting therapeutic effectiveness....
3.
Mantovani A, Marchesi F, Di Mitri D, Garlanda C
Cell Mol Immunol
. 2024 Oct;
21(11):1201-1214.
PMID: 39402303
Invasion and metastasis are hallmarks of cancer. In addition to the well-recognized hematogenous and lymphatic pathways of metastasis, cancer cell dissemination can occur via the transcoelomic and perineural routes, which...
4.
Pulvirenti A, Barbagallo M, Putignano A, Pea A, Polidori R, Upstill-Goddard R, et al.
Front Oncol
. 2024 Jul;
14:1405612.
PMID: 38988711
Introduction: Metabolic reprogramming is a hallmark feature of pancreatic ductal adenocarcinoma (PDAC). A pancreatic juice (PJ) metabolic signature has been reported to be prognostic of oncological outcome for PDAC. Integration...
5.
Zacchetti L, Brivio M, Mezzapesa M, Martinelli A, Punzi V, Monti M, et al.
Blood Purif
. 2024 Feb;
53(5):396-404.
PMID: 38402859
Introduction: Acute kidney injury (AKI) is frequent in critically ill COVID-19 patients and is associated with a higher mortality risk. By increasing intrathoracic pressure, positive pressure ventilation (PPV) may reduce...
6.
Erreni M, Fumagalli M, Zanini D, Candiello E, Tiberi G, Parente R, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338669
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. PDAC is characterized by a complex tumor microenvironment (TME), that plays a pivotal role in disease progression and resistance...
7.
Rigamonti A, Viatore M, Polidori R, Rahal D, Erreni M, Fumagalli M, et al.
Cancer Res
. 2024 Feb;
84(7):1165-1177.
PMID: 38315789
Significance: Leveraging artificial intelligence-powered H&E analysis integrated with hi-plex imaging mass cytometry provides insights into the tumor ecosystem and can translate tumor features into classifiers to predict prognosis, genotype, and...
8.
Trono P, Tocci A, Palermo B, Di Carlo A, DAmbrosio L, DAndrea D, et al.
J Immunother Cancer
. 2023 Aug;
11(8).
PMID: 37612043
Background: Understanding how cancer signaling pathways promote an immunosuppressive program which sustains acquired or primary resistance to immune checkpoint blockade (ICB) is a crucial step in improving immunotherapy efficacy. Among...
9.
Zacchetti L, Longhi L, Zangari R, Aresi S, Marchesi F, Gritti P, et al.
Front Neurol
. 2023 Apr;
14:1021020.
PMID: 37090991
Background: Older age is a well-known risk factor for unfavorable outcome in traumatic brain injury (TBI). However, many older people with TBI respond well to aggressive treatments, suggesting that chronological...
10.
Costa G, Sposito C, Soldani C, Polidoro M, Franceschini B, Marchesi F, et al.
Int J Surg
. 2023 Apr;
109(5):1311-1317.
PMID: 37037585
Introduction: Tumor-associated macrophages (TAMs) are key components of a tumoral microenvironment and have been shown to impact prognosis in different cancers. Previously reported data showed that TAM morphology correlates with...